CoolSculpting is the only non-surgical body contouring treatment that freezes and eliminates fat from your body. There are no needles, no special diets, no supplements and no downtime. Developed by Harvard scientists, CoolSculpting is FDA-cleared, safe, and proven effective.
Key Benefits of CoolSculpting
For the first time, patients who do not want the risk, cost and downtime associated with surgery or other invasive methods have a choice in CoolSculpting. With a customized treatment plan developed by an authorized CoolSculpting provider, patients can achieve dramatic results with this non-surgical procedure.
How CoolSculpting Works
During the CoolSculpting procedure, a non-invasive applicator delivers precisely controlled cooling to the treatment area to specifically target underlying fat, leaving surface skin and other surrounding tissue unaffected. When fat cells are exposed to extreme cold, a process of natural removal is triggered, with gradually reduces the thickness of the fat layer. The result is a noticeable and measurable reduction of fat in the treated area.
CoolSculpting results in a noticeable and measurable reduction of fat in the treated areas, and the treated fat cells are gone for good. Patients can start to see results as soon as three weeks following treatment, with the most dramatic results in as soon as three weeks following treatment, with the most dramatic results occurring after one to three months.
CoolSculpting is clinically proven to be a safe and effective treatment. With patented built-in safety measures including Freeze Detect, it is the only cold-based, non-surgical body contouring treatment that is cleared by the FDA. Patients can sit or lie comfortably and read, work on their laptop or even nap during the procedure. As said earlier, there are no needles, no special diets, no supplements and, most importantly, no downtime. CoolSculpting is performed in a medical office and under the supervision of a licensed physician.
CoolSculpting is U.S. FDA cleared and CE marked as a Class IIa medical device. It is performed by an elite global network of CoolSculpting Centers. To date, approximately 2,200 systems in 60 countries have performed more than 1,000,000 treatments worldwide. The complete list of licensed dermatologists, plastic surgeons and leading aesthetics practices offering the authentic, unique, patented CoolSculpting procedure can be found using the Physician Locator on CoolSculpting.com.
CoolSculpting is ideal for patients who are looking to transform their bodies without diet, exercise or surgery. It is not intended as a weight-reduction for overweight-reduction for overweight or obese individuals. The best candidates are people who are seeking fat reduction and are not considering a surgical procedure. Every patient is unique, which is why ZELTIQ recommends a customized treatment plan as part of the initial consultation. Additional treatments in the same or multiple areas may help enhance the desired aesthetic effect.
The Science Behind CoolSculpting
The CoolSculpting procedure developed by ZELTIQ is based on sound science called Cryolipolysis. Cryolipolysis is the result of a groundbreaking discovery by Drs. Dieter Manstein and R. Rox Anderson at the Wellman Center for photomedicine at Massachusetts General Hospital in Boston, a teaching affiliate of Harvard Medical School. ZELTIQ is the exclusive licensee of this patented technology and therefore the only company to provide Cryolipolysis.
Their initial work, first published in the peer-reviewed professional journal Lasers in Surgery and Medicine, proved that subcutaneous fat cells are naturally more vulnerable to the effects of could than other surrounding tissue. These studies and other clinical research from centers of excellence confirmed that fat cells, when exposed to precisely controlled cooling for a sustained period of time, undergo gradual reduction and cell death through a process called "induced apoptosis."
Founded in 2005, ZELTIQ Aesthetics, Inc (Nasdaq: ZLTQ) is a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform. It has licensed the exclusive commercial rights to Cryolipolysis from Massachusetts General Hospital as a non-invasive method of reducing fat. The company is advancing the science, clinical evaluation, and commercial development of this technology, Its first commercial product, the CoolSculpting system, is designed to safely, noticeably and measurably reduce fat. ZELTIQ is committed to using this breakthrough technology and making it available to physicians around the world specializing in cosmetic procedures.